ESG Data
2. Social
For the company, which provides services globally as a pharmaceutical development professional, our employees are the source of value creation. In order to expand business globally and increase corporate value sustainably in the rapidly changing healthcare industry, it is important that employees with diverse experience can demonstrate their abilities and characteristics to the maximum and continue to succeed.
To that end, we will develop a workforce who can make rapid progress as professionals in an era of change, and we will provide opportunities that enable each and every employee to demonstrate their abilities and characteristics to the maximum and pursue their own wellbeing.
Moreover, we will promote the development of the next generation of executives who can realize sustainable growth as a global company.
The Diversity of Employees:
a. Women
a. Women
【Headquarters (Japan)】
| End of Mar 2025 | End of Mar 2024 | End of Mar 2023 | |
| Ratio of Female Employees | 61.8% | 61.5% | 62.9% |
| Ratio of Female Managers | 39.4% | 42.6% | 44.2% |
| Ratio of Female Executive Officers | 16.7% | 16.7% | 16.7% |
【Consolidated (Group)】
| End of Mar 2025 | End of Mar 2024 | End of Mar 2023 | |
| Ratio of Female Employees | 68.1% | 68.1% | 68.5% |
| Ratio of Female Managers | 55.3% | 58.6% | 59.7% |
| Ratio of Female Executive Officers | 27.8% | 27.8% | 31.8% |
b. Foreign Nationals
b. Foreign Nationals
Our company does not set quantitative targets for the recruitment and promotion of non-Japanese to managerial positions due to the nature of the Company's business.
Regardless of nationality, we place importance on the abilities and strengths of the non-Japanese.
c. Mid-career Hires
c. Mid-career Hires
As of the end of March 2025, the ratio of mid-career employees at the head office in Japan was 48.8%, and the ratio of mid-career employees in managerial positions was 63.8%.